William Gray, M.D.
Call 484.476.1000
Dr. William Gray is system chief of the Division of Cardiovascular Disease at Main Line Health in Philadelphia and is the first president of Main Line Health’s Lankenau Heart Institute. He has served in cardiovascular leadership roles for nearly 20 years, most recently as director of endovascular services at New York-Presbyterian/Columbia University Medical Center. Dr. Gray launched and directed fellowship programs at Swedish Medical Center and the Cardiology Division of Columbia University College of Physicians and Surgeons.
Dr. Gray is board-certified in internal medicine, general cardiology and interventional cardiology, as well as in endovascular and vascular medicine. He earned his medical degree from Temple University School of Medicine. He completed an internal medicine residency and year as chief resident at Brown University/Rhode Island Hospital, where he also completed cardiology and interventional cardiology fellowships. Dr. Gray is a fellow of the American College of Cardiology and the Society for Cardiac Angiography and Intervention. He serves on the editorial board of JACC Cardiac Interventions and is a reviewer for several other peer-reviewed cardiovascular publications.
Specialties
- Interventional Cardiology
- Cardiovascular Disease
- Vascular Medicine
- Heart Care
- Cardiovascular Imaging Program
- Consultative Cardiology Program
- Coronary Artery Disease Program
- Peripheral Artery and Venous Disease Program
- Structural Heart and Valvular Disease Program
- Philadelphia International Medicine (PIM)
Practice Philosophy
The role of the Lankenau Heart Group physician is one of both educator and healer, with the focus to treat each individual patient to improve longevity and quality of life. Not every patient needs to be treated in the same way, and our physicians take the patient’s preference into account when tailoring a personalized course of treatment for them. We believe it is key to listen to our patient and their family members to make sure they have a complete understanding of their cardiac illness as well as their treatment options. For the best possible outcome, it is valuable for both the patient and their family to have a voice in the patient’s care and be invested in their treatment plan.
Comments